The Virtual Reality Room Targeting Type 2 Inflammation in Atopic Diseases: The Role of Interleukin Inhibitors

Target Audience
This activity is intended for U.S.-based pulmonologists, allergists, immunologists, otolaryngologists, pediatric/adolescent dermatologists, and other primary health care professionals (physicians, physician assistants, nurse practitioners) involved in the management of patients with atopic diseases including asthma, CRSwNP, and AD.

Program Overview
This online activity is focused on the team involved in the management of patients with type 2 inflammation in atopic diseases.

Learning Objectives
After completing the CME activity, learners should be better able to:

Describe the Th2 inflammatory pathways and cascades underlying the pathophysiology of atopic diseases including asthma, CRSwNP, and AD
Review the clinical profiles and mechanisms of action of interleukin inhibitors used for the treatment of atopic diseases including asthma, CRSwNP, and AD
Develop treatment plans for patients with atopic diseases including asthma, CRSwNP, and AD based on patient-specific factors relevant to clinical decision making